Illumina to Expand its Reach in Non-Invasive Prenatal Testing Across Europe

Illumina today announced that it has signed separate agreements with three companies,Biomnis, Genoma, and the Center for Human Genetics and Laboratory Diagnostics Martinsried, to expand its reach Non-Invasive Prenatal Testing in Europe. Under the agreement, these companies will uses Illumina’s HiSeq 2500, consumables to perform non-invasive prenatal testing (NIPT). Biomnis,a leading medical laboratory testing services […]

Natera to Launch its Non-Invasive Prenatal Test Panorama

Natera, one of the players in pre-natal genetic testing, will be launching its Non-Invasive Prenatal Test Panorama on 1st March. Natera’s Panorama can detect trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome) and sex chromosome abnormalities like monosomy X (Turner’s syndrome). Like other pre-natal testing companies, Natera’s test uses fetal cell-free […]

Illumina to Acquire Verinata Health – A Non-Invasive Pre-Natal Test Company

Illumina announced that it will be acquiring Verinata Health, a leading provider of non-invasive pre-natal tests for identifying fetal chromosomal abnormalities. As per the acquisition deal, Illumina will pay $350 million plus up to $100 million through 2015. Verinata Health, the California based company, has a product verifi prenatal test that can test pregnant woman’s blood and […]